These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24062074)
1. Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1. Yu SY; Qi R; Zhao H Mol Biol Rep; 2013 Nov; 40(11):6295-301. PubMed ID: 24062074 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409 [TBL] [Abstract][Full Text] [Related]
3. Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes. Chi-Xianggeng ; Hu-Bo ; Yu SY; Yin-Lianghong ; Meng-Yu ; Wang-Boxun ; Yang-Jinsheng ; Lin-Jiahui ; Huang-Dexu ; Chen-Lanlan J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1118-24. PubMed ID: 25795457 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714 [TBL] [Abstract][Full Text] [Related]
6. Role of nephrin in podocyte injury induced by angiotension II. Yu S J Recept Signal Transduct Res; 2016; 36(1):1-5. PubMed ID: 25264225 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. Lennon R; Welsh GI; Singh A; Satchell SC; Coward RJ; Tavaré JM; Mathieson PW; Saleem MA Diabetologia; 2009 Sep; 52(9):1944-52. PubMed ID: 19533082 [TBL] [Abstract][Full Text] [Related]
8. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116 [TBL] [Abstract][Full Text] [Related]
9. The CXCR4-AT1 axis plays a vital role in glomerular injury via mediating the crosstalk between podocyte and mesangial cell. Wu Q; Zhou S; Xu D; Meng P; Chen Q; Wang X; Li X; Chen S; Ye H; Ye W; Xiong Y; Li J; Miao J; Shen W; Lin X; Hou FF; Liu Y; Zhang Y; Zhou L Transl Res; 2024 Feb; 264():15-32. PubMed ID: 37696390 [TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy. Hudkins KL; Wietecha TA; Steegh F; Alpers CE Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614 [TBL] [Abstract][Full Text] [Related]
12. Role of CD2-associated protein in podocyte apoptosis and proteinuria induced by angiotensin II. Huang L; You YS; Wu W Ren Fail; 2014 Sep; 36(8):1328-32. PubMed ID: 24986244 [TBL] [Abstract][Full Text] [Related]
13. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury. Inoue K; Tian X; Velazquez H; Soda K; Wang Z; Pedigo CE; Wang Y; Cross E; Groener M; Shin JW; Li W; Hassan H; Yamamoto K; Mundel P; Ishibe S J Am Soc Nephrol; 2019 Dec; 30(12):2307-2320. PubMed ID: 31511362 [TBL] [Abstract][Full Text] [Related]
15. Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression. Gao H; Du WY; Lin J; Han SL; Zhang YJ; Sun XF Curr Med Sci; 2021 Jun; 41(3):505-512. PubMed ID: 34129205 [TBL] [Abstract][Full Text] [Related]
16. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes. Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212 [TBL] [Abstract][Full Text] [Related]
17. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy. Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468 [TBL] [Abstract][Full Text] [Related]
18. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Ren Z; Liang W; Chen C; Yang H; Singhal PC; Ding G Cell Signal; 2012 Feb; 24(2):443-450. PubMed ID: 21982880 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]